Lv1
30 积分 2025-09-07 加入
Hepatitis B reactivation in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based therapies: a pharmacovigilance analysis
1天前
已完结
Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy
1天前
已关闭
Reactivation of Resolved Hepatitis B After Daratumumab for Multiple Myeloma
1天前
已关闭
Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies
11天前
已完结
Daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma: final results from the phase 2 GEN501 and SIRIUS trials
11天前
已完结
Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopenia
12天前
已完结
Survival and relapse in patients with thrombotic thrombocytopenic purpura
12天前
已完结
Jalink M, Jacobs CF, Khwaja J, et al. Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease. Blood Adv. 2024;8(11):2622-2634
2个月前
已关闭
Bortezomib and daratumumab in refractory autoimmune hemolytic anemia
2个月前
已完结
Plasma cell‐directed therapy strategies in immune‐mediated thrombotic thrombocytopenic purpura (iTTP)
6个月前
已完结
皖公网安备34019202002308
